John Maher

Title: John Maher: Innovator in Immunotherapy

Introduction

John Maher is a prominent inventor based in London, GB. He has made significant contributions to the field of immunotherapy, holding a total of 7 patents. His work focuses on developing therapeutic agents that enhance the body's immune response against diseases.

Latest Patents

Among his latest patents is a groundbreaking invention related to immunoresponsive cells. This includes a T-cell expressing parallel chimeric activating receptors (pCAR), which are useful in therapy. Additionally, he has developed a method for expanding a population of γδ T-cells, utilizing isolated activated Peripheral Blood Mononuclear Cells (PBMCs) cultured in a medium containing transforming growth factor beta (TGF-β). This method is particularly aimed at producing effector γδ T-cells with therapeutic activity against malignant diseases.

Career Highlights

John Maher has worked with esteemed institutions such as King's College London and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His innovative research has positioned him as a key figure in the advancement of immunotherapy techniques.

Collaborations

Throughout his career, John has collaborated with notable colleagues, including Daniela Yordanova Achkova and Lynsey May Whilding. These partnerships have further enriched his research and contributions to the field.

Conclusion

John Maher continues to be a leading inventor in the realm of immunotherapy, with his patents paving the way for new therapeutic approaches. His work exemplifies the impact of innovation in medicine and the ongoing quest to improve patient outcomes.